v3.25.4
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Other Comprehensive Loss
Total
Balance at Jun. 30, 2024 $ 32,295 $ 38,089,958 $ (26,309,246) $ (118,819) $ 11,694,188
Balance (in shares) at Jun. 30, 2024 32,295,373        
Stock options expense   88,045     88,045
Restricted common stock expense   864,266     864,266
Grant of restricted common stock $ 590 (590)      
Grant of restricted common stock (in shares) 590,000        
Forfeited restricted common stock $ (229) 229      
Forfeited restricted common stock (in shares) (228,584)        
Repurchase of common stock $ (54) (205,224)     $ (205,278)
Repurchase of common stock (in shares) (53,889)        
Common stock issued upon exercise of stock options $ 38 (38)      
Common stock issued upon exercise of stock options (in shares) 37,507       111,821
Net income (loss) for the period     (1,311,230)   $ (1,311,230)
Foreign currency translation       (3,531) (3,531)
Balance at Dec. 31, 2024 $ 32,640 38,836,646 (27,620,476) (122,350) 11,126,460
Balance (in shares) at Dec. 31, 2024 32,640,407        
Balance at Sep. 30, 2024 $ 32,513 38,491,610 (25,640,242) (124,987) 12,758,894
Balance (in shares) at Sep. 30, 2024 32,513,172        
Stock options expense   59,189     59,189
Restricted common stock expense   475,133     475,133
Grant of restricted common stock $ 340 (340)      
Grant of restricted common stock (in shares) 340,000        
Forfeited restricted common stock $ (180) 180      
Forfeited restricted common stock (in shares) (180,000)        
Repurchase of common stock $ (48) (189,111)     (189,159)
Repurchase of common stock (in shares) (48,132)        
Common stock issued upon exercise of stock options $ 15 (15)      
Common stock issued upon exercise of stock options (in shares) 15,367        
Net income (loss) for the period     (1,980,234)   (1,980,234)
Foreign currency translation       2,637 2,637
Balance at Dec. 31, 2024 $ 32,640 38,836,646 (27,620,476) (122,350) 11,126,460
Balance (in shares) at Dec. 31, 2024 32,640,407        
Balance at Jun. 30, 2025 $ 32,480 39,059,557 (25,043,693) (120,187) 13,928,157
Balance (in shares) at Jun. 30, 2025 32,479,993        
Stock options expense   149,262     149,262
Restricted common stock expense   276,669     276,669
Grant of restricted common stock $ 95 (95)      
Grant of restricted common stock (in shares) 95,000        
Forfeited restricted common stock $ (420) 420      
Forfeited restricted common stock (in shares) (420,000)        
Repurchase of common stock $ (12) (39,537)     (39,549)
Repurchase of common stock (in shares) (11,982)        
Common stock issued upon exercise of stock options $ 245 157,255     $ 157,500
Common stock issued upon exercise of stock options (in shares) 245,469       268,500
Common stock issued for Scite earnout payment $ 487 1,452,941     $ 1,453,428
Common stock issued for Scite earnout payment (in shares) 486,996        
Net income (loss) for the period     1,296,306   1,296,306
Foreign currency translation       6,826 6,826
Balance at Dec. 31, 2025 $ 32,875 41,056,472 (23,747,387) (113,361) 17,228,599
Balance (in shares) at Dec. 31, 2025 32,875,476        
Balance at Sep. 30, 2025 $ 32,824 39,975,022 (24,294,306) (119,220) 15,594,320
Balance (in shares) at Sep. 30, 2025 32,823,996        
Stock options expense   90,556     90,556
Restricted common stock expense   122,893     122,893
Forfeited restricted common stock $ (390) 390      
Forfeited restricted common stock (in shares) (390,000)        
Repurchase of common stock $ (6) (16,156)     (16,162)
Repurchase of common stock (in shares) (5,592)        
Common stock issued upon exercise of stock options $ 225 157,275     157,500
Common stock issued upon exercise of stock options (in shares) 225,000        
Common stock issued for Scite earnout payment $ 222 726,492     726,714
Common stock issued for Scite earnout payment (in shares) 222,072        
Net income (loss) for the period     546,919   546,919
Foreign currency translation       5,859 5,859
Balance at Dec. 31, 2025 $ 32,875 $ 41,056,472 $ (23,747,387) $ (113,361) $ 17,228,599
Balance (in shares) at Dec. 31, 2025 32,875,476